Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

4 clinical studies listed.

Filters:

Proliferative Diabetic Retinopathy

Tundra lists 4 Proliferative Diabetic Retinopathy clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

COMPLETED

NCT07640256

Pain Management During Panretinal Photocoagulation for Diabetic Retinopathy: Safety and Efficacy of Peribulbar Anesthesia

The purpose of this study was to compare two different anesthesia methods for pain control during panretinal photocoagulation (PRP), a type of laser surgery that treats proliferative diabetic retinopathy (PDR). The study included eyes from patients with diabetes and proliferative diabetic retinopathy who were scheduled to undergo their first PRP session. Participants were split into two groups to receive either peribulbar anesthesia, which is a type of anesthesia injected through the eyelid, or a sham injection with topical anesthesia only. Pain on a numerical scale and vital signs were recorded before and for 15 minutes during PRP. These results were compared between the two groups to determine which method delivers superior pain control.

Gender: All

Ages: 18 Years - Any

Updated: 2026-07-14

1 state

Proliferative Diabetic Retinopathy
NOT YET RECRUITING

NCT07315802

New Pattern of Retinal Laser Treatment for PDR

The objective of the study is to evaluate the efficacy of a new pattern of argon-laser in treating patients with proliferative diabetic retinopathy (PDR).

Gender: All

Ages: 18 Years - 70 Years

Updated: 2026-01-20

1 state

Proliferative Diabetic Retinopathy
Photocoagulation Burn to Retina
RECRUITING

NCT06549023

Single Session vs Multiple-Session Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy

Proliferative diabetic retinopathy (PDR) is the leading cause for blindness in working-age adults. The current gold standard treatment for PDR is panretinal photocoagulation (PRP). In current clinical practice, both single-session and multiple-session PRP approaches are widely accepted and utilized. The purpose of this study is to compare the safety and effectiveness of single-session and multiple-session PRP.

Gender: All

Ages: 18 Years - Any

Updated: 2025-11-18

Proliferative Diabetic Retinopathy
Diabetic Retinopathy
Diabetic Retinopathy Visually Threatening
+3
ACTIVE NOT RECRUITING

NCT05393284

Phase 2 Spectra Study to Evaluate the Safety and Efficacy of OPL-0401 in Patients With Diabetic Retinopathy

OPL-0401-201 is a multicenter study to investigate the safety and efficacy of OPL-0401 in patients with diabetes mellitus (DM) with diabetic retinopathy.

Gender: All

Ages: 18 Years - Any

Updated: 2024-06-17

13 states

Non-proliferative Diabetic Retinopathy
Proliferative Diabetic Retinopathy